EXCELLENT study demonstrates real-world benefits of CERENOVUS’ EMBOTRAP™ Revascularization Devices on clinical outcomes and first pass reperfusion IRVINE, Calif., Nov. 18, 2022 /PRNewswire/ — CERENOVUS, Inc., part of Johnson & Johnson MedTech*, today announced positive primary outcomes from the real-world EXCELLENT Registry focused on […]